GYY4137 [morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate] (Cayman Chemicals, USA) and NaHS (Alfa Aesar, USA) were used as sources of H2S and were prepared according to the manufacturer’s instructions. While NaHS releases H2S instantaneously, GYY4137 is a water soluble H2S donor that releases H2S slowly for weeks both in vitro and in vivo24 (link),27 (link), and more closely parallels the biological effect of endogenous H2S. For H2S exposure experiments, a 10 mM GYY4137 stock solution was prepared in water in a 5 ml tube and was immediately diluted to make a working stock and added to cultures to achieve the desired final concentration. Experimental control samples received time-spent 25 µM GYY4137 (referred to as spent GYY) that was previously aerated for at least 120 days. An NaHS stock solution (100 mM) was prepared by equilibrating phosphate-buffered saline (PBS), made anoxic by bubbling with argon, with NaHS in a septum-sealed glass syringe. In order to avoid any trace metals catalyzing the oxidation of H2S, the metal chelator DTPA (diethylenetriaminepentaacetic acid) was added to the buffer to a final concentration of 50 µM prior to addition of NaHS. Photo-oxidation was prevented by wrapping the solution-containing syringe with aluminum foil. Despite these precautions, the presence of polysulfide in stock solutions cannot be completely excluded.
Free full text: Click here